Dr. Emily Andaya joins Louise Campbell and Roger Green to discuss the American Heart Association’s CKM initiative and why she believes it should include “L” for liver.
Physicians Who Run Multi-Metabolic Clinics in the US and Spain Join Louise Campbell To Discuss Their Clinics (Part I)
Physicians Who Run Multi-Metabolic Clinics in the US and Spain Join Louise Campbell To Discuss Their Clinics (Part I)
This episode focuses on “multi-metabolic medicine,” including a roundtable whose guests run multi-metabolic practices in the US and Spain and an interview with Dr. Emily Andaya, an advocate for including the liver in the American Heart Associations’s CKM initiative.
Predictive Health Intelligence Medical Director Tim Jobson joins Louise Campbell and Roger Green to provide an update on PHI’s Somerset project and other activities.
LiverRight CEO Brandon Tudor and Chief Medical Officer Alexander Lalos join Roger Green to discuss the launch of America’s first virtual hepatology clinic and the reason they created it.
First Six Months, Part I: Jörn Schattenberg cites two recent papers to describe the role proteomics might play in tailoring patient treatment plans.
In this conversation from April, Naim Alkhouri joins Roger Green to reminisce about his long relationship with Stephen Harrison and announce his (then) new role as Chief Academic Officer at Summit Clinical Research.
Fatty Liver Alliance President Mike Betel joined Roger Green to share some results and lessons from his 3rd Annual 30-day Glucose Challenge.
Behavioral Change consultant Dr. Kristina Curtis joins Jörn, Louise and Roger to discuss the unique challenges associated with weight loss through dieting and nutrition and ways government can support this effort.
